These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 31759264)

  • 41. Synthesis, structures and anticancer potentials of platinum(II) saccharinate complexes of tertiary phosphines with phenyl and cyclohexyl groups targeting mitochondria and DNA.
    Yilmaz VT; Icsel C; Turgut OR; Aygun M; Erkisa M; Turkdemir MH; Ulukaya E
    Eur J Med Chem; 2018 Jul; 155():609-622. PubMed ID: 29920455
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Potentially cytotoxic new copper(II) hydrazone complexes: synthesis, crystal structure and biological properties.
    Alagesan M; Bhuvanesh NS; Dharmaraj N
    Dalton Trans; 2013 May; 42(19):7210-23. PubMed ID: 23529726
    [TBL] [Abstract][Full Text] [Related]  

  • 43.
    Komarnicka UK; Niorettini A; Kozieł S; Pucelik B; Barzowska A; Wojtala D; Ziółkowska A; Lesiów M; Kyzioł A; Caramori S; Porchia M; Bieńko A
    Pharmaceuticals (Basel); 2022 Jan; 15(2):. PubMed ID: 35215281
    [TBL] [Abstract][Full Text] [Related]  

  • 44. In vitro antitumor activity of the water soluble copper(I) complexes bearing the tris(hydroxymethyl)phosphine ligand.
    Marzano C; Gandin V; Pellei M; Colavito D; Papini G; Lobbia GG; Del Giudice E; Porchia M; Tisato F; Santini C
    J Med Chem; 2008 Feb; 51(4):798-808. PubMed ID: 18251492
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Pyrazolone incorporating bipyridyl metallointercalators as effective DNA, protein and lung cancer targets: Synthesis, characterization and in vitro biocidal evaluation.
    Vyas KM; Devkar RV; Prajapati A; Jadeja RN
    Chem Biol Interact; 2015 Oct; 240():250-66. PubMed ID: 26341650
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Surfactant-copper(II) Schiff base complexes: synthesis, structural investigation, DNA interaction, docking studies, and cytotoxic activity.
    Lakshmipraba J; Arunachalam S; Solomon RV; Venuvanalingam P; Riyasdeen A; Dhivya R; Akbarsha MA
    J Biomol Struct Dyn; 2015; 33(4):877-91. PubMed ID: 24854148
    [TBL] [Abstract][Full Text] [Related]  

  • 47. In vitro and in vivo anticancer activity of copper(I) complexes with homoscorpionate tridentate tris(pyrazolyl)borate and auxiliary monodentate phosphine ligands.
    Gandin V; Tisato F; Dolmella A; Pellei M; Santini C; Giorgetti M; Marzano C; Porchia M
    J Med Chem; 2014 Jun; 57(11):4745-60. PubMed ID: 24793739
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mixed ligand μ-phenoxo-bridged dinuclear copper(II) complexes with diimine co-ligands: efficient chemical nuclease and protease activities and cytotoxicity.
    Loganathan R; Ramakrishnan S; Suresh E; Palaniandavar M; Riyasdeen A; Akbarsha MA
    Dalton Trans; 2014 Apr; 43(16):6177-94. PubMed ID: 24595529
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Synthesis, Characterization, and Biological Activities of Pendant Arm-Pyridyltetrazole Copper(II) Complexes: DNA Binding/Cleavage Activity and Cytotoxic Studies.
    Mustafa S; Rao BU; Surendrababu MS; Raju KK; Rao GN
    Chem Biodivers; 2015 Oct; 12(10):1516-34. PubMed ID: 26460557
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Designing, structural elucidation, comparison of DNA binding, cleavage, radical scavenging activity and anticancer activity of copper(I) complex with 5-dimethyl-2-phenyl-4-[(pyridin-2-ylmethylene)-amino]-1,2-dihydro-pyrazol-3-one Schiff base ligand.
    Sathiyaraj S; Sampath K; Butcher RJ; Pallepogu R; Jayabalakrishnan C
    Eur J Med Chem; 2013 Jun; 64():81-9. PubMed ID: 23644191
    [TBL] [Abstract][Full Text] [Related]  

  • 51. 2,6-Bis(2,6-diethylphenyliminomethyl)pyridine coordination compounds with cobalt(II), nickel(II), copper(II), and zinc(II): synthesis, spectroscopic characterization, X-ray study and in vitro cytotoxicity.
    Martinez-Bulit P; Garza-Ortíz A; Mijangos E; Barrón-Sosa L; Sánchez-Bartéz F; Gracia-Mora I; Flores-Parra A; Contreras R; Reedijk J; Barba-Behrens N
    J Inorg Biochem; 2015 Jan; 142():1-7. PubMed ID: 25282405
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Nitroimidazole and glucosamine conjugated heteroscorpionate ligands and related copper(II) complexes. Syntheses, biological activity and XAS studies.
    Pellei M; Papini G; Trasatti A; Giorgetti M; Tonelli D; Minicucci M; Marzano C; Gandin V; Aquilanti G; Dolmella A; Santini C
    Dalton Trans; 2011 Oct; 40(38):9877-88. PubMed ID: 21709917
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Hydroxyquinoline derived vanadium(IV and V) and copper(II) complexes as potential anti-tuberculosis and anti-tumor agents.
    Correia I; Adão P; Roy S; Wahba M; Matos C; Maurya MR; Marques F; Pavan FR; Leite CQF; Avecilla F; Costa Pessoa J
    J Inorg Biochem; 2014 Dec; 141():83-93. PubMed ID: 25226436
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Homoleptic phosphino copper(I) complexes with in vitro and in vivo dual cytotoxic and anti-angiogenic activity.
    Gandin V; Trenti A; Porchia M; Tisato F; Giorgetti M; Zanusso I; Trevisi L; Marzano C
    Metallomics; 2015 Nov; 7(11):1497-507. PubMed ID: 26190698
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Synthesis of copper/nickel nanoparticles using newly synthesized Schiff-base metals complexes and their cytotoxicity/catalytic activities.
    Aazam ES; El-Said WA
    Bioorg Chem; 2014 Dec; 57():5-12. PubMed ID: 25159596
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Redox-cycling and intercalating properties of novel mixed copper(II) complexes with non-steroidal anti-inflammatory drugs tolfenamic, mefenamic and flufenamic acids and phenanthroline functionality: Structure, SOD-mimetic activity, interaction with albumin, DNA damage study and anticancer activity.
    Simunkova M; Lauro P; Jomova K; Hudecova L; Danko M; Alwasel S; Alhazza IM; Rajcaniova S; Kozovska Z; Kucerova L; Moncol J; Svorc L; Valko M
    J Inorg Biochem; 2019 May; 194():97-113. PubMed ID: 30849593
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Copper(II) complexes with tridentate pyrazole-based ligands: synthesis, characterization, DNA cleavage activity and cytotoxicity.
    Gama S; Mendes F; Marques F; Santos IC; Carvalho MF; Correia I; Pessoa JC; Santos I; Paulo A
    J Inorg Biochem; 2011 May; 105(5):637-44. PubMed ID: 21450266
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Polynuclear zinc(II) complexes of thiosemicarbazone: Synthesis, X-ray structure and biological evaluation.
    Saswati ; Mohanty M; Banerjee A; Biswal S; Horn A; Schenk G; Brzezinski K; Sinn E; Reuter H; Dinda R
    J Inorg Biochem; 2020 Feb; 203():110908. PubMed ID: 31683125
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Dinuclear copper(I) complexes containing cyclodiphosphazane derivatives and pyridyl ligands: synthesis, structural studies, and antiproliferative activity toward human cervical and breast cancer cells.
    Balakrishna MS; Suresh D; Rai A; Mague JT; Panda D
    Inorg Chem; 2010 Oct; 49(19):8790-801. PubMed ID: 20812680
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Strong effect of copper(II) coordination on antiproliferative activity of thiosemicarbazone-piperazine and thiosemicarbazone-morpholine hybrids.
    Bacher F; Dömötör O; Chugunova A; Nagy NV; Filipović L; Radulović S; Enyedy ÉA; Arion VB
    Dalton Trans; 2015 May; 44(19):9071-90. PubMed ID: 25896351
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.